摘要:
The present disclosure relates to inhibitors of zinc-dependent histone deacetylases (HDACs) useful in the treatment of diseases or disorders associated with an HDAC, e.g., HDAC6, having a Formula I: where R, L, X1, X2, X3, X4, Y1, Y2, Y3, and Y4 are described herein.
摘要:
The present disclosure relates to inhibitors of zinc-dependent histone deacetylases (HDACs) useful in the treatment of diseases or disorders associated with an HDAC, e.g ., HDAC6, having a Formula I:, where R, L, X 1 , X 2 , X 3 , X 4 , Y 1 , Y 2 , Y 3 , and Y 4 are described herein.
摘要:
Die Erfindung betrifft neue 1,4-Cycloalkanooxazepine der allgemeinen Formel worin
R 1 ein Wasserstoffatom, eine Hydroxygruppe oder eine Alkoxy- oder Acyloxygruppe mit 1 bis 4 Kohlenstoffatomen, R2 einen Kohlenwasserstoffrest mit 1 bis 3 Kohlenstoffatomen, n die Zahl 1, 2 oder 3 und x die Zahl 0 oder 1
bedeutet, sowie deren Salze mit physiologisch verträglichen Säuren; Verfahren zu deren Herstellung; und deren Anwendung in der Therapie. Die neuen Substanzen eignen sich zur Pharmakotherapie von Schmerzzuständen verschiedener Ursache.
摘要:
The present disclosure relates to inhibitors of zinc-dependent histone deacetylases (HDACs) useful in the treatment of diseases or disorders associated with an HDAC, e.g., HDAC6, having a Formula I:
where R, L, X 1 , X 2 , X 3 , X 4 , Y 1 , Y 2 , Y 3 , and Y 4 are described herein.
wherein ring A represents an optionally substituted aromatic ring; T represents an optionally substituted hydrogen atom or an optionally substituted hydrocarbon group; X represents -CH₂-, -CO- or -CH(OH)-; D represents - CH₂-, -O- or -NR- wherein R is a hydrogen atom or an optionally substituted hydrocarbon group and m, e and f independently represent an integer from 1 to 3, or a salt thereof, which excellently inhibits a monoamine uptake, monoamine oxidase B and/or Ca ion uptake, and is useful as a prophylactic and therapeutic drug for a central nervous diseases.